Business · Markets · 1 hr ago
Jim Cramer backs Jazz Pharmaceuticals as shares fall
Jim Cramer backed Jazz Pharmaceuticals, a pharmaceutical company.
Its shares have fallen over the past month, despite Cramer's support.
The story does not give a reason for the decline.
It also does not explain what prompted Cramer's backing.
No specific next step or forecast is provided.
The key point is that Cramer remains supportive while the stock has been falling.
Jim Cramer backed Jazz Pharmaceuticals as its shares fell.
Jazz shares had fallen during the past month, according to TheStreet.
TheStreet described Cramer’s support as a vote of confidence.
The article did not explain why Cramer backed the stock.
- Who
- Jim Cramer backed Jazz Pharmaceuticals.
- What
- Cramer expressed support for the company’s stock as its shares fell.
- When
- TheStreet article was published on 2026-10-14.
- Where
- Not stated.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Company
- Jazz Pharmaceuticals
- Person
- Jim Cramer
- Publication date
- 2026-10-14
Related
Bank of America faces more than $1.2 billion in penalties
29 mins ago · 11 sources
Bumble agrees to $1.3 billion buyout and will go private
43 mins ago · 7 sources
Getty Images plans Chapter 11 restructuring and move to private ownership
51 mins ago · 6 sources
Character.ai files for bankruptcy as Disney makes $20 million opening bid
1 hr ago · 4 sources
